跳至主要内容
临床试验/NL-OMON41318
NL-OMON41318已完成不适用

FAME study: Fecal Administration for eradication of Multiresistant ESBL producing bacteria in carriers - FAME trial

Academisch Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • ESBL carriage demonstrated in stool, rectum, perineum or urine
  • able to give informed consent
  • Life expectancy of three months or more

排除标准

  • 1. (Expected) prolonged compromised immunity due to high dose prednisolone, recent cytotoxic chemotherapy for a malignancy, or HIV infection with a CD4 count < 350 cells/L
  • 2. Ileus or signs of diminished bowel passage, or altered anatomical situation which prohibits normal passage of a donor feces infusion
  • 3. Admission to intensive care or vasopressive dependency at time of inclusion
  • 4. Known food allergy to peanuts, wheat, tree nuts, shellfish, fish, milk, sesame, chickpeas or eggs, or other dietary factors that could be accidentally infused with a donor feces infusion.

研究者

相似试验